SPY336.84+0.01 0.00%
DIA279.80+0.38 0.14%
IXIC11,019.30-23.20 -0.21%

UBS Downgrades Allergan to Neutral, Raises Price Target to $203

UBS downgrades Allergan (NYSE:AGN) from Buy to Neutral and raises the price target from $189 to $203.

Benzinga · -

UBS downgrades Allergan (NYSE:AGN) from Buy to Neutral and raises the price target from $189 to $203.